| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
| | | | | ZentiSita 25 mg | 28 | PR | PR | k.A. | | Coated tablets: Sitagliptinum 25 mg | Helvepharm AG | B | FB | | G |  |
| | | | | ZentiSita 25 mg | 98 | PR | PR | k.A. | | Coated tablets: Sitagliptinum 25 mg | Helvepharm AG | B | FB | | G |  |
| | | | | ZentiSita 50 mg | 28 | PR | PR | k.A. | | Coated tablets: Sitagliptinum 50 mg | Helvepharm AG | B | FB | | G |  |
| | | | | ZentiSita 50 mg | 98 | PR | PR | k.A. | | Coated tablets: Sitagliptinum 50 mg | Helvepharm AG | B | FB | | G |  |
| | | | | ZentiSita 100 mg | 28 | PR | PR | k.A. | | Coated tablets: Sitagliptinum 100 mg | Helvepharm AG | B | FB | | G |  |
| | | | | ZentiSita 100 mg | 98 | PR | PR | k.A. | | Coated tablets: Sitagliptinum 100 mg | Helvepharm AG | B | FB | | G |  |
L | | IP | CI | | Januvia 100 mg - T | 28 Tablet(s) | 26.82 | 44.80 | 20 % | | Coated tablets: 2 Active Agents | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Januvia 100 mg - T | 98 Tablet(s) | 93.85 | 115.75 | 20 % | | Coated tablets: 2 Active Agents | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Januvia 25 mg - T | 28 Tablet(s) | 26.82 | 44.80 | 20 % | | Coated tablets: Sitagliptinum 25 mg | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Januvia 25 mg - T | 98 Tablet(s) | 93.85 | 115.75 | 20 % | | Coated tablets: Sitagliptinum 25 mg | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Januvia 50 mg - T | 28 Tablet(s) | 26.82 | 44.80 | 20 % | | Coated tablets: Sitagliptinum 50 mg | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Januvia 50 mg - T | 98 Tablet(s) | 93.85 | 115.75 | 20 % | | Coated tablets: Sitagliptinum 50 mg | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Sitagliptin Spirig HC 25 mg. Filmtabletten | 28 | 14.08 | 31.75 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Spirig HC 50 mg. Filmtabletten | 28 | 14.08 | 31.75 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Spirig HC 100 mg. Filmtabletten | 28 | 14.08 | 31.75 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin Spirig HC 25 mg. Filmtabletten | 98 | 49.25 | 70.00 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Spirig HC 50 mg. Filmtabletten | 98 | 49.25 | 70.00 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Spirig HC 100 mg. Filmtabletten | 98 | 49.25 | 70.00 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin Spirig HC 25 mg. Filmtabletten | 100 | 50.26 | 71.05 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Spirig HC 50 mg. Filmtabletten | 100 | 50.26 | 71.05 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Spirig HC 100 mg. Filmtabletten | 100 | 50.26 | 71.05 | 10 % | | Sitagliptini Hydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin NOBEL 25 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 25 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin NOBEL 25 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 25 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin NOBEL 50 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 50 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin NOBEL 50 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 50 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin NOBEL 100 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 100 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin NOBEL 100 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 100 mg | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin Sandoz eco 25 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 25 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin Sandoz eco 25 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 25 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Sandoz eco 50 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 50 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Sandoz eco 50 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 50 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Sandoz eco 100 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 100 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Sandoz eco 100 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 100 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin Zentiva 25 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 25 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin Zentiva 25 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 25 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Zentiva 50 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 50 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Zentiva 50 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 50 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Zentiva 100 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 100 mg | Helvepharm AG | ● B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin Zentiva 100 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 100 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin-Mepha 25 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 25 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Sitagliptin-Mepha 25 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 25 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin-Mepha 50 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 50 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin-Mepha 50 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 50 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin-Mepha 100 mg | 28 | 14.08 | 31.75 | 10 % | | Coated tablets: Sitagliptinum 100 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | IP | | | Sitagliptin-Mepha 100 mg | 98 | 49.25 | 70.00 | 10 % | | Coated tablets: Sitagliptinum 100 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |